chr4-99930564-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001031723.4(DNAJB14):c.191G>A(p.Arg64Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,612,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001031723.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB14 | NM_001031723.4 | c.191G>A | p.Arg64Gln | missense_variant | 2/8 | ENST00000442697.7 | NP_001026893.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB14 | ENST00000442697.7 | c.191G>A | p.Arg64Gln | missense_variant | 2/8 | 1 | NM_001031723.4 | ENSP00000404381.2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250044Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135162
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1460186Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 726324
GnomAD4 genome AF: 0.000112 AC: 17AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.191G>A (p.R64Q) alteration is located in exon 2 (coding exon 2) of the DNAJB14 gene. This alteration results from a G to A substitution at nucleotide position 191, causing the arginine (R) at amino acid position 64 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at